CD44 and breast carcinoma: Furthermore, p27CK-DD expression in MCF12A causes a shift from predominantly CD44low/CD24+ to a greater population expressing stem cell surface markers, CD44+CD24low/- (Fig. 1f left), a hall mark of breast cancer initiating cells or CSCs2.